Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

PURPOSE To investigate the impact of human papillomavirus (HPV) on the epidemiology of oral squamous cell carcinomas (OSCCs) in the United States, we assessed differences in patient characteristics, incidence, and survival between potentially HPV-related and HPV-unrelated OSCC sites. PATIENTS AND METHODS Data from nine Surveillance, Epidemiology, and End Results program registries (1973 to 2004) were used to classify OSCCs by anatomic site as potentially HPV-related (n = 17,625) or HPV-unrelated (n = 28,144). Joinpoint regression and age-period-cohort models were used to assess incidence trends. Life-table analyses were used to compare 2-year overall survival for HPV-related and HPV-unrelated OSCCs. RESULTS HPV-related OSCCs were diagnosed at younger ages than HPV-unrelated OSCCs (mean ages at diagnosis, 61.0 and 63.8 years, respectively; P < .001). Incidence increased significantly for HPV-related OSCC from 1973 to 2004 (annual percentage change [APC] = 0.80; P < .001), particularly among white men and at younger ages. By contrast, incidence for HPV-unrelated OSCC was stable through 1982 (APC = 0.82; P = .186) and declined significantly during 1983 to 2004 (APC = -1.85; P < .001). When treated with radiation, improvements in 2-year survival across calendar periods were more pronounced for HPV-related OSCCs (absolute increase in survival from 1973 through 1982 to 1993 through 2004 for localized, regional, and distant stages = 9.9%, 23.1%, and 18.6%, respectively) than HPV-unrelated OSCCs (5.6%, 3.1%, and 9.9%, respectively). During 1993 to 2004, for all stages treated with radiation, patients with HPV-related OSCCs had significantly higher survival rates than those with HPV-unrelated OSCCs. CONCLUSION The proportion of OSCCs that are potentially HPV-related increased in the United States from 1973 to 2004, perhaps as a result of changing sexual behaviors. Recent improvements in survival with radiotherapy may be due in part to a shift in the etiology of OSCCs.

[1]  K. Shah,et al.  Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. , 2004, The Journal of infectious diseases.

[2]  S C Shiboski,et al.  Trends in oral cancer rates in the United States, 1973-1996. , 2000, Community dentistry and oral epidemiology.

[3]  M. Gillison,et al.  Current topics in the epidemiology of oral cavity and oropharyngeal cancers , 2007, Head & neck.

[4]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[5]  L. Turek,et al.  Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx , 2003, International journal of cancer.

[6]  A. Carvalho,et al.  Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER database , 2005, International journal of cancer.

[7]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[8]  N. Schlecht.  Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence. , 2005, Oncology reports.

[9]  A R Feinstein,et al.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.

[10]  Hyune-Ju Kim,et al.  Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351 , 2001 .

[11]  R. Weber,et al.  Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival , 2006, The Laryngoscope.

[12]  Guo-Pei Yu,et al.  Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. , 2002, Archives of otolaryngology--head & neck surgery.

[13]  J. Laissue,et al.  Human papillomavirus positive squamous cell carcinoma of the oropharynx , 2001, Cancer.

[14]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[15]  R. Tarone,et al.  Evaluation of birth cohort patterns in population disease rates. , 1996, American journal of epidemiology.

[16]  J. Pignon,et al.  Individual patients' data meta-analyses in head and neck cancer , 2007, Current opinion in oncology.

[17]  Deborah Schrag,et al.  Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. , 2005, Journal of the National Cancer Institute.

[18]  E. Munck‐Wikland,et al.  Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer , 2006, International journal of cancer.

[19]  M. Gillison,et al.  Clinical implications of human papillomavirus in head and neck cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  B. Schmidt,et al.  Tongue and tonsil carcinoma , 2005, Cancer.

[21]  Brian O'Sullivan,et al.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.

[22]  A. Jemal,et al.  Lung cancer rates convergence in young men and women in the United States: Analysis by birth cohort and histologic type , 2003, International journal of cancer.

[23]  J. Fraumeni,et al.  Oral and pharyngeal cancers. , 1994, Cancer surveys.

[24]  S. Schwartz,et al.  Human Papillomavirus Infection and Survival in Oral Squamous Cell Cancer: A Population-Based Study , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[25]  J. Fraumeni,et al.  Cohort Trends in Mortality from Oral, Esophageal, and Laryngeal Cancers in the United States , 1990, Epidemiology.

[26]  M. Gillison.  Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  D. Rimm,et al.  Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  B Carstensen,et al.  Age–period–cohort models for the Lexis diagram , 2007, Statistics in medicine.

[29]  M. Gillison,et al.  Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. , 2004, Seminars in oncology.

[30]  Premarital sexual experience among adolescent women--United States, 1970-1988. , 1991, MMWR. Morbidity and mortality weekly report.

[31]  Robert E. Johnson,et al.  Herpes Simplex Virus Type 2 in the United States, 1976 to 1994 , 1997 .

[32]  J. Rehm,et al.  Age, period and cohort influences on beer, wine and spirits consumption trends in the US National Alcohol Surveys. , 2004, Addiction.

[33]  D. Lindquist,et al.  Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients , 2004, International journal of cancer.

[34]  G. Mcquillan,et al.  Herpes simplex virus type 2 in the United States, 1976 to 1994. , 1998, The New England journal of medicine.

[35]  D. Winn,et al.  Smoking and drinking in relation to oral and pharyngeal cancer. , 1988, Cancer research.

[36]  R. Biggar,et al.  Changing patterns of tonsillar squamous cell carcinoma in the United States , 2000, Cancer Causes & Control.

[37]  K. Dietz,et al.  Bmc Cancer , 2022 .

[38]  T. Holford.  Understanding the effects of age, period, and cohort on incidence and mortality rates. , 1991, Annual review of public health.

[39]  S. Devesa,et al.  Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. , 2002, Oral oncology.